BACKGROUND: Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in selected patients with non-small-cell lung cancer. METHODS: In this phase 3, open-label study, we randomly assigned previously untreated patients in East Asia who had advanced p...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!